B7H3 CAR-T cell therapy has been utilized to treat a variety of solid tumors, including neuroblastoma, glioblastoma, atypical teratoma/rhabdomyoma, and Ewing’s sarcoma [19, 28, 29]. This evidence concerns the gene CD276 and glioblastoma.